Clinical Trial Update: Sickle Cell Trait and the Risk of Venous Thromboembolism

View source ↗

Summary

Termination of a clinical trial evaluating sickle cell trait and risk of venous thromboembolism; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Trait
• Venous Thromboembolism

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Thrombosis | Status: TERMINATED | Results posted: 2020-01-02